Part 1 Introduction and front matter<br>1. Plastic surgery, fat, and fat plasticity: How adipose tissue changed the landscape of stem cell therapeutics<br>Lauren Kokai and J. Peter Rubin<br>Part 2 Basic biology of adipose stem cells<br>2. Developmental origins of adipocytes: What we learn from human pluripotent stem cells <br>Xi Yao, Vincent Dani, and Christian Dani<br>3. Establishing the adipose stem cell identity: Characterization assays and functional properties<br>Mark A.A. Harrison, Sara I. Al-Ghadban, Benjamen T. O’Donnell, Omair A. Mohiuddin, Rachel M. Wise, Brianne N. Sullivan, and Bruce A. Bunnell<br>4. Insights into the adipose stem cell niche in health and disease<br>Aaron C. Brown<br>5. Mechanisms of adipose-derived stem cell aging and the impact on therapeutic potential<br>Xiaoyin Shan and Ivona Percec<br>6. Human pluripotent nontumorigenic multilineage differentiating stress enduring (Muse) cells isolated from adipose tissue: A new paradigm in regenerative medicine and cell therapy<br>Karen L. Leung and Gregorio D. Chazenbalk<br>7. Adipose stem cell homing and routes of delivery <br>Ganesh Swaminathan, Yang Qiao, Bhavesh D. Kevadiya, Lucille A. Bresette, Daniel D. Liu, and Avnesh S. Thakor<br>8. Bioreactors and microphysiological systems for adipose-based pharmacologic screening<br>Mallory D. Griffin and Rosalyn D. Abbott<br>Part 3 Adipose cell therapy and regenerative medicine<br>9. Adipose stem cells and donor demographics: Impact of anatomic location, donor sex, race, BMI, and health<br>Adam Cottrill, Yasamin Samadi, and Kacey G. Marra<br>10. Immunomodulatory properties of adipose stem cells in vivo: Preclinical and clinical applications<br>Matthias Waldner, Fuat Baris Bengur, and Lauren Kokai<br>11. Clinical experience with adipose tissue enriched with adipose stem cells<br>Shawn Loder, Danielle Minteer, and J. Peter Rubin<br>12. Adipose-derived stem cells for wound healing and fibrosis<br>Y Samadi, FM Egro, RL Rodriguez, and A Ejaz<br>13. Oncologic safety of adipose-derived stem cell application<br>Hakan Orbay and David E. Sahar<br>14. FDA regulation of adipose cell use in clinical trials and clinical translation<br>Mary Ann Chirba, Veronica Morgan Jones, Patsy Simon, and Adam J. Katz<br>Part 4 Engineering with adipose stem cell<br>15. Biomaterial control of adipose-derived stem/stromal cell differentiation<br>John Walker and Lauren Flynn<br>16. Genetic modification of adipose-derived stem cells for bone regeneration<br>Harsh N. Shah, Abra H. Shen, Sandeep Adem, Ankit Salhotra, Michael T. Longaker, and Derrick C. Wan<br>17. Adipose-derived stromal/stem cells for bone tissue engineering applications<br>Nathalie Faucheux, Fabien Kawecki, Jessica Jann, Franc¸ois A. Auger, Roberto D. Fanganiello, and Julie Fradette<br>18. The hematopoietic potential of stem cells from the adipose tissue<br>Beatrice Cousin and Louis Casteilla<br>19. Adipose stem cells for peripheral nerve engineering<br>Benjamin K. Schilling, George E. Panagis, Jocelyn S. Baker, and Kacey G. Marra<br>
